KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Taxes: 2009-2012

Historic Change in Taxes for Bausch Health Companies (BHC) over the last 4 years, with Dec 2012 value amounting to $34.6 million.

  • Bausch Health Companies' Change in Taxes rose 1994.57% to $34.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $20.7 million, marking a year-over-year increase of 233.57%. This contributed to the annual value of $20.7 million for FY2012, which is 233.57% up from last year.
  • Per Bausch Health Companies' latest filing, its Change in Taxes stood at $34.6 million for Q4 2012, which was up 11,211.58% from -$311,000 recorded in Q3 2012.
  • Bausch Health Companies' Change in Taxes' 5-year high stood at $34.6 million during Q4 2012, with a 5-year trough of -$15.1 million in Q2 2012.
  • For the 3-year period, Bausch Health Companies' Change in Taxes averaged around -$376,667, with its median value being -$587,000 (2011).
  • In the last 5 years, Bausch Health Companies' Change in Taxes tumbled by 1,296.59% in 2010 and then skyrocketed by 1,994.57% in 2012.
  • Quarterly analysis of 4 years shows Bausch Health Companies' Change in Taxes stood at -$850,000 in 2009, then plummeted by 1,296.59% to -$11.9 million in 2010, then surged by 84.63% to -$1.8 million in 2011, then surged by 1,994.57% to $34.6 million in 2012.
  • Its Change in Taxes was $34.6 million in Q4 2012, compared to -$311,000 in Q3 2012 and -$15.1 million in Q2 2012.